5. Case scenario 1
• 25 year female, primi presented to labor ward with 9 months
pregnancy with convulsions 6-7 episodes. On examination her BP
was 170/100 and she was irritable.....What next
6. Maternal management
Stabilize patient-ABC
Turn women to left lateral
position
Is the cause Eclampsia
(Hypertension/proteinuria
Magnesium sulphate for seizures
(monitor Spo2,patellar reflex,UO)
Control BP(labetalol)
Benzodiazepines(Lz,MID,diazepam
First line AED-
phenytoin,leveracetam,valproate
Yes
No
Seizure
not
controlled
Until other causes are
excluded, however, all
pregnant women with
convusions should be
considered to be eclampsia
7. Intubation and anaesthetic agents: MID/propofol
/thiopentone sodium
Choice between additional AED or Intubation
and anaesthetic agents
First line AED-phenytoin, leveracetam, valproate
10. Fetal management
I,II trimester
Sev PE/
Use of drug with high
teratogenicity
MTP
Regular monitoring and
deliver near term
yes
no
III trimester
Sev PE/RSE
deliver Gestational age
yes no
24-32weeks 34-37 weeks 37 weeks
Regular monitoring
steroids
Steroids
Deliver after48hrs
deliver
11. Fetal complications
• Preterm delivery(15-67%)
• IUGR(10-25%)
• Hypoxia/neuronal injury(<1%)
• Perinatal death(1-2%)
• Long term cardiovascular abnormality associated with low birth
weight
12. Case scenario 2
• Primi, known epileptic ,16 weeks pregnant on
carbamazepine now complaining of 2-3 episode of
convulsions. on examination her BP was normal.
Neurological examination is normal. what next.....
13. Differences between epilepsy and eclampsia
• Eclampsia
• Occurs after 20 weeks of
pregnancy
• Convusions are tonic
clonic
• History of PIH in this
pregnancy
• History of
hypertension,proteinuria,
edema, pulmonary
edema
• Epilepsy
• Occurs at anytime in
pregnancy
• Convulsions can be
focal/generalised
• H/o of previous epileptic
fits
• No H/o of
hypertension/proteinuria
14. Increased seizure frequency due to
a. Decreased and subtherapeutic anticonvulsant serum levels
b. Lower seizure threshold
Decreased AED levels due to:
Nausea and vomiting
Decreased GIT motility
Antacid use causing decreased absorbtion
Pregnancy hypervolumia
Increased hepatic and placental enzymes causing drug
metabolism
Increased GFR causing drug clearance.(Williams 24
edition)
Effects of Epilepsy on mother
15. • Increased fetal malformations
Women should be informed that the risk of congenital abnormalities in the
fetus is dependent on the type, number and dose of AEDs(RCOG June
2016).
Monotherapy preferred over polytherapy.
Prepregnancy folic acid 5 mg/day may be helpful in reducing the risk of
AED-related cognitive deficit.
The fetal anomaly scan at 18+0–20+6 weeks of gestation can identify
major cardiac defects in addition to neural tube defects.
Effect of epilepsy on fetus
17. Antenatal
• Main goal is seizure prevention
• Accomplished by
Treatment of nausea and vomiting
Medication compliance emphasized
Seizure provoking stimuli avoided
Fewest necessary anticonvulsants are given at lowest effective
dose
• Fetal anomaly scan at 18-20 weeks.
management
18. Intranatal
o Continue seizure prophylaxis. If seizures manage acutely
with benzodiazepines and antiepileptics like phynetoin.
o epilepsy per se is not an indication for planned caesarean
section or induction of labour.
o To prevent haemorrhagic disease of the newborn babies born
to WWE taking enzyme-inducing AEDs should be offered 1
mg of intramuscular vitamin K.(RCOG June 2016)
o Adequate analgesia and appropriate care in labour should
be provided to minimise risk factors for seizures such as
insomnia, stress and dehydration.
o Long-acting benzodiazepines such as clobazam can be
considered if there is a very high risk of seizures in the
peripartum period.
19. • Postnatal
Breastfeeding not contraindicated
Contraception:
IUCDs and MPA injections should be promoted as reliable methods of
contraception.(RCOG June 2016)
Efficacy of hormonal contraceptives decreased if they are taking
enzyme-inducing AEDs (e.g. carbamazepine, phenytoin,
phenobarbital, primidone, oxcarbazepine and eslicarbazepine).
All methods of contraception may be offered to women taking
non-enzyme-inducing AEDs (e.g. sodium valproate,
levetiracetam, gabapentin, vigabatrin, tiagabine and
pregabalin).